HEBELPRODUKT/Open End-Tur/ DE000TR9YZ50 /

3/21/2023 9:35:03 AM	Chg.0.000	Bid9:58:12 AM	Ask9:58:12 AM	Underlying	Strike price	Expiration date	Option type
8.040EUR	0.00%	8.030 Bid Size: 10,000	8.130 Ask Size: 10,000	AMGEN INC. DL-...	149.1463 -	12/31/2078	Call

TeleTrader 2/1 Dow dips 200 pts at open as markets brace for Fed guidance

TeleTrader 1/31 Amgen: Net income down 15% in Q4 to $1.6 billion

TeleTrader 1/31 Dow up by 200 pts ahead of interest rate decision

TeleTrader 12/12/2022 US stocks end strong day, Dow up over 500 pts

TeleTrader 12/12/2022 US kicks off with gains as markets brace for rate hikes

TeleTrader 12/12/2022 Amgen to buy Horizon for $26.4 billion

TeleTrader 12/11/2022 Amgen close to buying Horizon, worth over $20B - report

TeleTrader 11/8/2022 US stocks close higher amid midterm elections

TeleTrader 11/8/2022 US stocks rally as markets brace for midterm elections

TeleTrader 11/4/2022 US opens higher after nonfarm payrolls report

TeleTrader 11/3/2022 Amgen sees EPS soaring 20% to $3.98 in Q3

TeleTrader 11/3/2022 US closes lower ahead of another batch of earnings

TeleTrader 11/3/2022 Wall Street opens lower after Fed hikes rate again

TeleTrader 10/24/2022 US closes higher with major earnings reports in focus

TeleTrader 10/24/2022 Wall Street extends gains, Dow soars 500 points

TeleTrader 10/24/2022 US markets open mostly higher amid earnings releases

TeleTrader 10/19/2022 Dow falls 250 pts as Wall Street changes course again

TeleTrader 10/11/2022 Wall Street closes mostly lower after BoE warning

TeleTrader 8/31/2022 US opens higher with economy in focus

TeleTrader 8/4/2022 Amgen's Q2 EPS triples to $2.45

TeleTrader 8/4/2022 US closes mostly lower after labor market data

TeleTrader 8/4/2022 US opens mostly flat after trade, jobs data

TeleTrader 6/2/2022 Wall Street opens lower amid data

GlobeNewswire 3/23/2022 CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors

GlobeNewswire 3/23/2022 OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Bio...